Adherium Limited is a respiratory eHealth company specializing in patient adherence, remote monitoring, and data management solutions for individuals with chronic respiratory conditions such as asthma and COPD. The company’s flagship Hailie Smartinhaler technology, paired with a secure cloud-based data platform, enables healthcare providers, payers, and patients to track medication usage, improve treatment outcomes, and reduce healthcare costs. Adherium Limited’s solutions are designed to support better disease management and facilitate data-driven decision-making across the healthcare ecosystem. The company is headquartered in Melbourne and operates globally, focusing on digital health innovation within the medical technology sector. Adherium Limited is listed on the CHI-X Market Australia - Limit Venue, providing investors with exposure to a niche segment of the healthcare technology industry.